Cargando…
Gastric Cancer Heterogeneity and Clinical Outcomes
Gastric adenocarcinoma is a highly aggressive disease with poor overall survival. The aggressive nature of this disease is in part due to the high intra and inter tumoral heterogeneity and also due to the late diagnosis at presentation. Once progression occurs, treatment is more difficult due to the...
Autores principales: | Sexton, Rachel E., Hallak, Mohammed Najeeb Al, Uddin, Md. Hafiz, Diab, Maria, Azmi, Asfar S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432987/ https://www.ncbi.nlm.nih.gov/pubmed/32799763 http://dx.doi.org/10.1177/1533033820935477 |
Ejemplares similares
-
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
por: Nagasaka, Misako, et al.
Publicado: (2021) -
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside
por: Uddin, Md. Hafiz, et al.
Publicado: (2021) -
Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs
por: Li, Yiwei, et al.
Publicado: (2021) -
Connecting the Human Microbiome and Pancreatic Cancer
por: Sexton, Rachel E., et al.
Publicado: (2022) -
Correction to: Connecting the human microbiome and pancreatic cancer
por: Sexton, Rachel E., et al.
Publicado: (2022)